Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines to meet the major unmet medical needs of patients on a global basis.

Find out more.

News

  • October 24, 2014

    Sucampo Pharmaceuticals, Inc. Announces Third Quarter 2014 Earnings Call

  • October 23, 2014

    Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs

  • October 21, 2014

    Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)

  • October 14, 2014

    Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda